TNNI3 and metabolic syndrome: Patients with hs-cTnI elevation exhibited a comparable cerebrovascular risk profile and disease burden with regard to their prior medical history, including arterial hypertension, hypertensive heart disease, atrial fibrillation, dyslipidemia, and CAD {18.5 versus (vs.)14.7%; [χ2 (1, N = 493) = 0.814, p = 0.367]}.